![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Mutschler, Nikola S.; Scholz, Christoph; Friedl, Thomas W. P.; Zwingers, Thomas; Fasching, Peter A.; Beckmann, Matthias W.; Fehm, Tanja; Mohrmann, Svjetlana; Salmen, Jessica; Ziegler, Carola; Jaeger, Bernadette; Widschwendter, Peter; Gregorio, Nikolaus de; Schochter, Fabienne; Mahner, Sven; Harbeck, Nadia; Weissenbacher, Tobias; Jückstock, Julia; Janni, Wolfgang und Rack, Brigitte
(2018):
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
In: Clinical Breast Cancer, Bd. 18, Nr. 2: S. 175-183
Rack, Brigitte; Jückstock, Julia; Trapp, Elisabeth; Weissenbacher, Tobias; Alunni-Fabbroni, Marianna; Schramm, Amelie; Widschwendter, Peter; Lato, Krisztian; Zwingers, Thomas; Lorenz, Ralf; Tesch, Hans; Schneeweiss, Andreas; Fasching, Peter; Mahner, Sven; Beckmann, Matthias W.; Lichtenegger, Werner und Janni, Wolfgang
(2016):
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
In: Tumor Biology, Bd. 37, Nr. 10: S. 13769-13775
Schönherr, Alexandra; Aivazova-Fuchs, Viktoria; Annecke, Katja; Jückstock, Julia K.; Hepp, Philip; Andergassen, Ulrich; Augustin, Doris; Simon, Wolfgang; Wischnik, Arthur; Mohrmann, Svjetlana; Salmen, Jessica; Zwingers, Thomas; Kiechle, Marion; Harbeck, Nadia; Friese, Klaus; Janni, Wolfgang und Rack, Brigitte
(2012):
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
In: Breast Care, Nr. 4: S. 289-295
[PDF, 207kB]